Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SUNHYDROGEN, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
0
Research and development
0.14
0.25
0.53
0.62
2
1.79
3.44
2.57
3.44
4.33
Selling and marketing
0.11
0.37
0.13
0.05
0
0.09
General and administrative
0.46
0.5
1.29
1.06
3.67
2.27
5.65
2.34
2.34
3.05
Operating expenses
0.6
0.75
1.83
1.68
5.81
4.48
9.27
5
5.82
7.52
Operating income
-0.6
-0.75
-1.83
-1.68
-5.81
-4.48
-9.27
-5
-5.82
-7.52
Interest expense
0.35
0.33
0.83
0.93
0.56
0.54
0.07
0
0
Interest income
1.15
2.01
1.74
1.24
Other non-operating income
2.85
-9.45
5.81
-55.8
-75.7
94.5
10.2
-4.88
-2.41
0.99
Pre-tax income
-15.7
18.9
0.2
Net income to minority interests
-57.5
-81.5
Net income
2.24
-10.2
3.98
-57.5
-81.5
90
0.97
-9.88
-8.23
-6.53
EBITDA
-0.6
-0.75
-1.82
-1.67
-5.78
-4.43
-9.22
-4.96
-5.78
-7.48
EPS, basic
0.00
-0.01
0.00
-0.04
-0.04
0.02
0.00
0.00
0.00
0.00
EPS, diluted
0.00
-0.01
0.00
-0.04
-0.04
0.02
0.00
0.00
0.00
0.00
Shares, basic (weighted)
638
759
925
1,552
2,757
4,103
4,492
5,028
5,319
5,533
Shares, diluted (weighted)
961
759
925
1,552
2,757
5,218
4,787
5,028
5,319
5,533
Dividend per share
0.03
0.02
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
0.08
0.1
0.04
0.2
56
27.7
37.2
39
34.6
12.1
Short-term investments
24.3
3.19
3
19.9
Receivables
0.4
Other current assets
0
0
0.02
0.01
0
0.07
0.18
Total current assets
0.08
0.1
0.05
0.2
56
52
48
43.1
37.7
32.7
Property, plant and equipment
0
0
0
0.16
0.12
0.12
0.16
0.15
0.12
Lease right-of-use assets
0.1
Intangible assets
0.08
0.09
0.1
0.07
0.06
0.05
0.05
Long-term investments
3
Other non-current assets
0.08
Total assets
0.17
0.2
0.15
0.29
56.2
52.2
51.2
43.4
37.9
32.9
Accounts payable
0.1
0.11
0.13
0.22
0.06
0.23
Accrued liabilities
0.4
0.47
0.18
-0
0.01
0
0
0.14
0.15
0.29
Total current liabilities
3.23
11.8
4.88
60.7
136
27.2
0.34
0.76
0.67
0.86
Lease liabilities
0.04
Total liabilities
4.42
13.2
6.66
62.1
137
27.3
0.38
0.76
0.67
0.91
Total debt
1.27
0.83
Paid-in capital
6.85
8.13
10.4
11.7
88.6
103
127
128
131
133
Retained earnings
-11.8
-22
-18
-75.6
-173
-82.9
-82
-91.9
-100
-107
Other comprehensive income
-0.01
Shareholders' equity
-4.25
-13
-6.51
-61.8
-80.6
24.6
49.7
41.7
36.6
31.8
Total equity
-4.25
-13
-6.51
-61.8
-80.6
24.6
49.7
41.7
36.6
31.8
Total liabilities and equity
0.17
0.2
0.2
0.29
56.2
52.2
51.2
43.4
37.9
32.9
Shares outstanding
852
852
1,077
2,053
3,849
4,272
4,821
5,087
5,438
5,749
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
2.24
-10.2
3.98
57.5
81.5
90
0.97
-9.88
-8.23
-6.53
Depreciation and amortization
0
0.01
0.01
0.01
0.02
0.04
0.04
0.04
0.04
0.04
Stock-based compensation
0
0.03
0.74
0.47
0.26
0.96
0.02
1.31
0.67
1.17
Change in payables
0.03
0.01
0.01
0.08
0.02
-0.17
0.18
0.34
-0.05
-0.02
Cash from operations
-0.57
-0.71
-0.85
-0.7
-5.38
-3.44
-4.26
-1.84
-3.65
-5.07
Capital expenditures
-0
-0.01
-0
-0.21
-0.03
-0.02
-0.02
-0
Purchases of investments
-24.4
-82
-8.01
-26.2
Sales and maturities of investments
103
Cash from investing
-0.04
-0.02
-0.01
-0
-0.17
-24.4
11.1
2.92
-2.92
-17.2
Debt repaid
-0.06
Stock issued
62.2
0.96
2.73
0.88
2.2
1.17
Cash from financing
0.58
0.75
0.8
0.86
61.4
-0.49
2.67
0.78
2.16
-0.23
Exchange rate effect
-0
Net change in cash
-0.04
0.02
-0.06
0.16
55.8
-28.3
9.5
1.86
-4.42
-22.5
Free cash flow
-0.71
-0.87
-0.7
-5.59
-4.3
-1.87
-3.66
-5.07
Interest paid
0
0
0
0.03
0.01
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $0.02 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-601,652.0%
Operating income / revenue.
EBITDA margin
-598,362.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-522,522.0%
Net income / revenue.
FCF margin
-405,429.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-405,229.0%
Cash from operations / revenue.
Return on equity (ROE)
-19.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-18.4%
Net income / average total assets.
Return on invested capital (ROIC)
-55.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
346,678.0%
Research and development expense / revenue.
Stock-based pay / revenue
93,359.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
200.8%
Capital expenditures / revenue.
D&A / revenue
3,291.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-13.2%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-13.9%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-13.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-13.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-10.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
4.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
15.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
37.9x
Current assets / current liabilities.
Quick ratio
37.6x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
37.2x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.00
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.00
Revenue / diluted weighted shares.
FCF per share
-$0.00
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
$0.01
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
82,788x
Market cap / revenue.
P/B
3.26x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.26x
Market cap / tangible book value, when positive.
EV/Sales
57,140x
Enterprise value / revenue.
FCF yield
-4.9%
Free cash flow / market cap.
Earnings yield
-6.3%
Net income / market cap (the inverse of P/E).
What was SUNHYDROGEN, INC.'s revenue in fiscal 2026?
SUNHYDROGEN, INC. reported revenue of $1.3K for fiscal 2026.
Was SUNHYDROGEN, INC. profitable in fiscal 2026?
No. It reported a net loss of $6.5M.
How much free cash flow did SUNHYDROGEN, INC. generate in fiscal 2026?
Cash from operations of $5.1M minus capital expenditures of $2.5K left free cash flow of -$5.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.